Screener
Fulcrum Therapeutics, Inc. FULC Q2 2026 earnings
Reported July 30, 2026 · Before market open
EPS-$0.21Beat by $0.03
EPS estimate-$0.24
Next report
Oct 29, 2026 (in a month)EPS estimate-$0.13
Versus estimates
Diluted EPS
FAQ
- When did Fulcrum Therapeutics, Inc. report Q2 2026 earnings?
- Fulcrum Therapeutics, Inc. (FULC) reported Q2 2026 earnings on July 30, 2026 before market open.
- What were Fulcrum Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Fulcrum Therapeutics, Inc. reported eps of $-0.21 for Q2 2026.
- Did Fulcrum Therapeutics, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.24 by $0.03.
- How did Fulcrum Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 25.0% from $-0.28.
- Where can I find Fulcrum Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001193125-26-326098) directly on SEC EDGAR. The filing index links above go to sec.gov.
